This special edition reports from our United Through Diabetes 2023 event - our biggest ever Wellness Day, celebrating 25 years of DRWF. Hear from our speakers, experts, researchers, attending UTD.
In this edition, we’re looking at the impact of DRWF’s research funding in stimulating vital early development of new treatments and therapies. We’ve been talking to researchers who have gone on to win major funding under the Grand Challenge, a project funded by a £50 million donation from the Steve Morgan Foundation aimed at improving the lives of people with Type 1 diabetes.
Today we’re looking at the use of continuous glucose monitoring devices (CGMs) for both type 1 and type 2 diabetes. Claire Levy talks with Jake Leach, the chief operating officer of CGM developer and manufacturer Dexcom, from their US headquarters in San Diego, California.
